Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMW-SD in Islet Transplantation for Type 1 Diabetes
NCT00789308Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jul 2008
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, open-label trial of ilb in type 1 diabetes mellitus (T1D), sponsored by National Institute of Allergy and Infectious Diseases. Started Jul 2008; status: completed.
02
Drugs
ilb
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00789308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00789308.